Last updated 2026-08-12
Portfolio
2
in our dataset
Rounds participated
3
Rounds led
1
Rounds' value
$86.0M
total disclosed, rounds participated
Stages
Early Stage, Growth Stage
About
Tadmor Group is a prominent Israeli investment group that specializes in initiating, managing, financing, and scaling ventures to commercial success. The group manages the diverse portfolio of Mr. Gideon Tadmor, with interests spanning Energy, Data Centers, Real Estate, Entertainment, Healthcare, and Technology. Headquartered in Israel with a global reach, Tadmor Group focuses on transforming small-scale opportunities into sustainable and scalable enterprises, often acting as a strategic co-investor alongside top-tier Israeli VCs in early-stage and growth-stage tech ventures.
Portfolio · 2
Q&A
- What is Tadmor Group's primary investment focus?
- Tadmor Group is an Israeli investment group that specializes in initiating, managing, financing, and scaling ventures across diverse sectors, including Energy, Data Centers, Real Estate, Entertainment, Healthcare, and Technology.
- What kind of investment stages does Tadmor Group target?
- Tadmor Group invests in both Early Stage and Growth Stage companies.
- Where is Tadmor Group headquartered and what are its preferred geographies for investment?
- Tadmor Group is headquartered in Tel Aviv, Israel, and prefers to invest in Israel, the US, and Europe.
- Who is the founder and chairman of Tadmor Group?
- Gideon Tadmor is the Founder and Chairman of Tadmor Group.
- What is Tadmor Group's investment thesis?
- Tadmor Group focuses on transforming small-scale opportunities into sustainable and scalable enterprises, utilizing financial leverage, strategic insight, and hands-on business expertise.
- Does Tadmor Group typically co-invest with other firms?
- Yes, Tadmor Group often acts as a strategic co-investor alongside top-tier Israeli VCs in early-stage and growth-stage tech ventures.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 52 |
|---|